Centre d'Appui à la lutte contre la Maladie Report issue

Academic/Hospital Phase 4

Organization Overview

First Clinical Trial
2001
NCT02784743
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2010

Timeline

NOW
  • Now

Active Ingredients

Drugs in Phase 4 Trials (2)

albendazole (Albenza) (2 trials)

ivermectin (stromectol) (2 trials)

Drugs in Other Trials (1)

azithromycin (zithromax) (1 trial)

Indications

Experimental Indications (Clinical Trials, Phases 1-4)


 

Elephantiasis (Phase 4)

Elephantiasis, Filarial (Phase 4)

Filariasis (Phase 4)

Overview

  • Highest Phase: Phase 4
  • # of Trials: 2
  • # of Trial APIs: 3